Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 3,952.3 | 2,070.4 | 1,064.3 | 1,075.9 |
Revenue growth | 90.9% | 94.5% | -1.1% | |
Cost of goods sold | 3,769.9 | 1,862.6 | 976.5 | 1,001.5 |
Gross profit | 182.4 | 207.8 | 87.8 | 74.4 |
Gross margin | 4.6% | 10.0% | 8.2% | 6.9% |
Sales and marketing | 238.9 | 146.9 | 76.8 | 85.2 |
Research and development | 12.1 | 10.9 | 7.3 | 7.5 |
General and administrative | 58.7 | 30.3 | 17.5 | 15.1 |
EBIT | -127.3 | 19.8 | -13.8 | -33.4 |
EBIT margin | -3.2% | 1.0% | -1.3% | -3.1% |
Pre-tax income | -148.3 | 6.6 | -23.0 | -51.7 |
Income taxes | 0.4 | 0.2 | 0.2 | 0.3 |
Tax rate | | 2.6% | | |
Net income | -148.6 | 6.5 | -23.1 | -52.0 |
Net margin | -3.8% | 0.3% | -2.2% | -4.8% |
|
Diluted EPS | ($0.61) | $0.05 | ($0.40) | ($0.90) |
Shares outstanding (diluted) | 245.1 | 143.2 | 57.9 | 57.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|